Retractable Technologies (RVP) Assets Average (2011 - 2026)
Retractable Technologies' (RVP) quarterly Assets Average came in at $139.6 million in Q2 2026, down 5.77% on a YoY basis from $148.2 million in Q2 2025, and little changed quarter-over-quarter from $140.1 million in Q1 2026.
Analysis
Retractable Technologies (RVP) Assets Average (2011 - 2026) Analysis & Trends
Retractable Technologies (RVP) has reported Assets Average for 16 consecutive years, with $139.6 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Assets Average fell 5.77% year-over-year to $139.6 million; the trailing twelve-month figure through Jun 2026 stood at $139.6 million (down 5.77% YoY), and the FY2025 full-year result was $151.7 million, down 10.88% from the prior year.
- Assets Average steadied at $139.6 million in Q2 2026 per RVP's latest filing, from $140.1 million in the prior quarter.
- Across five years, Assets Average topped out at $206.9 million in Q1 2022 and bottomed at $139.6 million in Q2 2026.
- Historically, Assets Average has averaged $171.8 million across 5 years, with a median of $173.1 million in 2024.
- The sharpest annual moves came in 2022 and 2024: Assets Average jumped 70.01% in 2022, then fell 13.5% in 2024.
- Over 5 years, Assets Average stood at $198.1 million in 2022, then fell by 8.85% to $180.6 million in 2023, then declined by 11.81% to $159.3 million in 2024, then dropped by 9.25% to $144.5 million in 2025, then slipped by 3.38% to $139.6 million in 2026.
- According to Business Quant data, Assets Average over the past three periods registered $139.6 million, $140.1 million, and $144.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Becton Dickinson | 48.35 Bn | 47.49 Bn | 2.32 Bn | 50.78 Bn |
| 2 | Medline | 28.03 Bn | 25.36 Bn | 2.22 Bn | 39.18 Bn |
| 3 | West Pharmaceutical Services | 24.14 Bn | 23.71 Bn | 329.20 Mn | 4.09 Bn |
| 4 | Baxter International | 12.44 Bn | 10.29 Bn | 1.03 Bn | 19.82 Bn |
| 5 | Stevanato Group S.p.A | 5.68 Bn | 5.57 Bn | 100.91 Mn | 3.03 Bn |
| 6 | Acme United | 234.01 Mn | 228.97 Mn | 26.69 Mn | 197.94 Mn |
| 7 | Rockwell Medical | 30.24 Mn | 5.45 Mn | 3.24 Mn | 56.97 Mn |
| 8 | Retractable Technologies | 21.15 Mn | -18.72 Mn | 190,852.00 | 139.65 Mn |
| 9 | United Health Products | 8.85 Mn | 8.82 Mn | - | 248,405.00 |
| 10 | Cuprina Holdings (Cayman) | 7.88 Mn | 4.76 Mn | - | 8.41 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 139.65 Mn |
| Mar 31, 2026 | 140.11 Mn |
| Dec 31, 2025 | 144.53 Mn |
| Sep 30, 2025 | 146.76 Mn |
| Jun 30, 2025 | 148.20 Mn |
| Mar 31, 2025 | 155.02 Mn |
| Dec 31, 2024 | 159.27 Mn |
| Sep 30, 2024 | 159.28 Mn |
| Jun 30, 2024 | 168.36 Mn |
| Mar 31, 2024 | 177.82 Mn |
| Dec 31, 2023 | 180.59 Mn |
| Sep 30, 2023 | 184.14 Mn |
| Jun 30, 2023 | 190.21 Mn |
| Mar 31, 2023 | 194.66 Mn |
| Dec 31, 2022 | 198.12 Mn |
| Sep 30, 2022 | 197.43 Mn |
| Jun 30, 2022 | 200.89 Mn |
| Mar 31, 2022 | 206.90 Mn |
| Dec 31, 2021 | 192.15 Mn |
| Sep 30, 2021 | 176.85 Mn |